- Home
- ALLK vs AMOD Comparison
ALLK vs AMOD Comparison
Compare ALLK & AMOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALLK
- AMOD
- Stock Information
- Founded
- ALLK 2012
- AMOD 2014
- Country
- ALLK United States
- AMOD United States
- Employees
- ALLK N/A
- AMOD N/A
- Industry
- ALLK Biotechnology: Pharmaceutical Preparations
- AMOD
- Sector
- ALLK Health Care
- AMOD
- Exchange
- ALLK Nasdaq
- AMOD NYSE
- Market Cap
- ALLK 23.0M
- AMOD 16.5M
- IPO Year
- ALLK 2018
- AMOD N/A
- Fundamental
- Price
- ALLK $0.32
- AMOD $1.36
- Analyst Decision
- ALLK Hold
- AMOD
- Analyst Count
- ALLK 3
- AMOD 0
- Target Price
- ALLK $2.00
- AMOD N/A
- AVG Volume (30 Days)
- ALLK 1.8M
- AMOD 181.5K
- Earning Date
- ALLK 03-12-2025
- AMOD 05-15-2025
- Dividend Yield
- ALLK N/A
- AMOD N/A
- EPS Growth
- ALLK N/A
- AMOD N/A
- EPS
- ALLK N/A
- AMOD N/A
- Revenue
- ALLK N/A
- AMOD N/A
- Revenue This Year
- ALLK N/A
- AMOD N/A
- Revenue Next Year
- ALLK N/A
- AMOD N/A
- P/E Ratio
- ALLK N/A
- AMOD N/A
- Revenue Growth
- ALLK N/A
- AMOD N/A
- 52 Week Low
- ALLK $0.22
- AMOD $1.20
- 52 Week High
- ALLK $1.56
- AMOD $13.49
- Technical
- Relative Strength Index (RSI)
- ALLK 59.90
- AMOD N/A
- Support Level
- ALLK $0.24
- AMOD N/A
- Resistance Level
- ALLK $0.27
- AMOD N/A
- Average True Range (ATR)
- ALLK 0.01
- AMOD 0.00
- MACD
- ALLK 0.01
- AMOD 0.00
- Stochastic Oscillator
- ALLK 96.94
- AMOD 0.00
About ALLK Allakos Inc.
Allakos Inc is a clinical-stage company developing therapeutic antibodies that selectively target immunomodulatory receptors present on the surface of immune effector cells involved in allergic, inflammatory, and proliferative diseases. The company's program, AK006 targets Siglec-6, an inhibitory receptor expressed selectively on mast cells. Binding of AK006 to Siglec-6 is designed to activate the native inhibitory function of the receptor which in turn reduces mast cell activation. Its portfolio consists of antibodies that target receptors, particularly Siglec-6, Siglec-8 and other anti-Siglec antibodies, including some antibodies in preclinical development.
About AMOD ALPHA MODUS HOLDINGS INC
Alpha Modus Holdings Inc is a technology company with a core focus on artificial intelligence in retail. It is engaged in creating, developing and licensing data-driven technologies to enhance consumers' in-store digital experience at the point of decision.